Of note, a considerable and durable T cell-mediated suppression of tumor growth was observed when PTPN6 knockdown of OT-I T cells was combined with anti-PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunotherapy (205). The gene discussed is CTLA4; the disease is neoplasm.